Clinical and financial impact of intravenous erythromycin therapy in hospitalized patients

Annals of Pharmacotherapy

Volumn 33, Issue 6, 1999, Pages 669-673

  Classen, David C ^a   Burke, John P ^b   Pestotnik, Stanley L ^c   Lloyd, James F ^c  

^a UNIVERSITY OF UTAH   (United States)

^b LDS HOSPITAL   (United States)

^c NONE

Author keywords

Erythromycin; Health care costs; Pharmacoeconomics

Indexed keywords

ERYTHROMYCIN;

ABDOMINAL CRAMP; ANTIBIOTIC THERAPY; ARTICLE; CONTROLLED STUDY; COST CONTROL; DRUG COST; DRUG UTILIZATION; ERYTHEMA; FEMALE; HEALTH CARE COST; HOSPITAL COST; HOSPITALIZATION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; NAUSEA; PAIN; PHLEBITIS; PRIORITY JOURNAL; REGRESSION ANALYSIS; VOMITING;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; COHORT STUDIES; COST-BENEFIT ANALYSIS; DIAGNOSIS-RELATED GROUPS; ERYTHROMYCIN; FEMALE; HOSPITALIZATION; HUMANS; INJECTIONS, INTRAVENOUS; LENGTH OF STAY; MALE; MIDDLE AGED; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES;

EID: 0033057271     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.18251     Document Type: Article

References (22)

1. Nash DB, Goldfarb NI. Exploring resource use in high-cost versus low-cost care: the pharmaceutical example. DRG Monitor 1987;4(8):1-8.
2. Sloan FA, Gordon GS, Cocks DL. Hospital drug formularies and use of hospital services. Med Care 1993;31:851-67.
3. Bootman JL, Townsend RJ, McGhan WF. Introduction to pharmacoeconomics. In: Bootman JL, Townsend RJ, McGhan WF, eds. Principles of pharmacoeconomics. Cincinnati: Harvey Whitney Books, 1991:3-17.
4. McDonald CJ, Tierney WM. Computer-stored medical records. Their future role in medical practice. JAMA 1988;259:3433-40.
5. Classen DC, Pestotnik SL, Evans RS, Burke JP. Computerized surveillance of adverse drug events in hospitalized patients. JAMA 1991;266: 2847-51.
6. Classen DC, Pestotnik SL, Evans RS, Lloyd JF, Burke JP. Adverse drug events in hospitalized patients: excess length of stay, extra costs, and attributable mortality. JAMA 1997;277:301-6.
7. Periti P, Mazzei T, Mini E, Novelli A. Adverse effects of macrolide antibacterials. Drug Saf 1993 (Nov);9(5):346-64.
8. Pryor TA, Gardner RM, Clayton PD, Warner HR. The HELP system. J Med Syst 1983;7:87-102.
9. Kuperman GJ, Gardner RM, Pryor TA. HELP: a dynamic hospital information system. New York: Springer-Verlag, 1991.
10. Hulse RK, Clark SJ, Jackson JC, Warner HR, Gardner RM. Computerized medication monitoring system. Am J Hosp Pharm 1976;33:1061-6.
11. Evans RS, Larsen RA, Burke JP, Gardner RM, Meier FA, Jacobson JA, et al. Computer surveillance of hospital-acquired infections and antibiotic use. JAM A 1986;256:1007-11.
12. The LDS Hospital nurse acuity system. Nursing care manual, Salt Lake City: LDS Hospital, 1990.
13. Standard cost manager: user's guide. Cleveland: Ernst and Whinney Inc., National Health Care Group, 1987.
14. Haley RW. Measuring the cost of nosocomial infections: methods for estimating the economic burden on the hospital. Am J Med 1991:91:325-85.
15. Haley RW. Cost benefit analysis of infection control programs. In: Bennett JV, Brachman PS, eds. Hospital infections. Boston: Little, Brown, 1992.
16. Polissar L, Diehr P. Regression analysis in health services research: the use of dummy variables. Med Care 1982;20:959-66.
17. Huth TS, Burke JP. Infections and antibiotic use in a community hospital, 1971-1990. Infect Control Hosp Epidemiol 1991;12:525-34.
18. Bowler WA, Hostettler C, Samuelson D, Lavin BS, Oldfield EC. Gastrointestinal side effects of intravenous erythromycin: incidence and reduction with prolonged infusion time and glycopyrrolate treatment. Am J Med 1992;692:249-53.
19. Von-Rosensteil NA, Adam D. Macrolide antibacterials. Drug interactions of clinical significance. Drug Saf 1995 (Aug); 13(2): 105-22.
20. Putzi R, Blaser J, Luthy R, Wehrli R, Siegenthaler W. Side effects due to the intravenous infusion of erythromycin lactobionate. Infection 1983; 11:45-7.
21. Horwitz RI, Viscoli CM, Clemens JD, Sadock RT. Developing improved observational methods for evaluating therapeutic effectiveness. Am J Med 1990;89:630-8.
22. Sacks H, Chalmers TC, Smith H. Randomized versus historical control for clinical trials. Am J Med 1982;72:233-40.